You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
News on diagnostic systems for drugs of abuse and toxicology.
The company is looking to grow uptake of its products in a variety of life science markets ranging from toxicology testing to biopharma research.
Prescient offers a test that is designed to determine an individual's risk of opioid addiction by analyzing 16 genes in the brain's reward pathway.
The firm plans to launch 10 new products next year, but analysts were cautious about Quidel's prospects moving forward.
Researchers associated with the International Cannabis Consortium and 23andMe found a causal relationship between schizophrenia and cannabis use.
The guidelines are the first to attempt to specify which drugs are appropriate to test for routinely, guideline authors say.
European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.
Science reports that Science Foundation Ireland is seeking annual budget increases.
According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.
In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.